Document Detail


Experience with progesterone gel for luteal support in a highly successful IVF programme.
MedLine Citation:
PMID:  10831556     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Efficacy of luteal support from single daily administration of Crinone((R)) 8% (progesterone gel) was tested in 43 women in an IVF programme with historical pregnancy rates >50%. Results were compared with those achieved in 46 women concurrently undergoing IVF and receiving 50 mg i.m. progesterone, and with historical data. Pregnancy rates (PR) were evaluated approximately 2 weeks after undergoing IVF by human chorionic gonadotrophin (HCG) measurement (total PR), by ultrasound 2-4 weeks later (clinical PR), and by counting births. Prior experience with other progesterone formulations was compared with that of Crinone 8%. Demographic and IVF characteristics were comparable for both concurrently treated groups. Total PR, clinical PR and live birth rates were similar for the Crinone and the concurrent i.m. progesterone groups: 31 (72.1%) versus 34 (73.9%); 26 (60.5%) versus 28 (60.9%), and 23 (53.5%) versus 23 (50%) respectively. Clinical PR and live birth rates were also similar to the last data reported to the Society for Assisted Reproduction Therapy. Overall acceptability of Crinone 8% was excellent. Among subjects with prior i.m. injection experience, most patients (69.2%) agreed that the gel was easier to use, less painful (76.9%) and less time-consuming (61.5%) than i.m. injections. In conclusion, Crinone 8% offers an appreciable improvement, as it provides an effective luteal support option that avoids painful i.m. injections.
Authors:
W B Schoolcraft; J S Hesla; M J Gee
Related Documents :
18472646 - A multiple marker model to predict pregnancy viability when progesterone is indeterminate.
21256486 - Pregnancy rate and outcome in swedish women with turner syndrome.
21195476 - Elsevier trophoblast research award lecture: the multifaceted role of nodal signaling d...
1916216 - Progestins and cortisol delay while estradiol-17 beta induces early parturition in the ...
11601676 - Prediction of the development of pregnancy-induced hypertensive disorders in high-risk ...
20383986 - Reproductive performance measures among thoroughbred mares in central kentucky, during ...
Publication Detail:
Type:  Comparative Study; Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Human reproduction (Oxford, England)     Volume:  15     ISSN:  0268-1161     ISO Abbreviation:  Hum. Reprod.     Publication Date:  2000 Jun 
Date Detail:
Created Date:  2000-07-25     Completed Date:  2000-07-25     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  8701199     Medline TA:  Hum Reprod     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  1284-8     Citation Subset:  IM    
Affiliation:
Colorado Center for Reproductive Medicine, Englewood, Colorado 80110, USA. ccrm@colocrm.com
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Birth Rate
Corpus Luteum / drug effects*,  physiology
Female
Fertilization in Vitro*
Gels
Humans
Injections, Intramuscular
Patient Acceptance of Health Care
Pregnancy
Pregnancy Outcome
Pregnancy Rate
Progesterone / administration & dosage,  analogs & derivatives*,  therapeutic use
Chemical
Reg. No./Substance:
0/Crinone; 0/Gels; 57-83-0/Progesterone

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Should ICSI be the treatment of choice for all cases of in-vitro conception?
Next Document:  Increased frequency of mutations in DNA from infertile men with meiotic arrest.